β-Aminoarteether  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

件 库存{{model.attbuying.number}}件
包装规格:1mg in glass bottle
产品描述:基本信息 产品编号: A11747 产品名称: β-Aminoarteether CAS: 133162-24-0   储存条件 粉末 -20℃ 四年     分子式: C17H29NO5 溶于液体   两年 分子量 327.42     化学名:  2-(((3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl)oxy)ethanamine   生物活性 产品描述 一种具有口服活性的 Artemisinin 衍生物。β-Aminoarteether 可用于炎症和自身免疫性疾病的研究,例如狼疮疾病。 体外研究 β-Aminoarteether (SM934;10µM; 24 hours) treatment directly enhances IL-10 production and suppresses IL-12/23p40 production in primary peritoneal macrophages with IFN-γ stimulation. In vitro, β-Aminoarteether (SM934) could suppress the Th1 and Th17 polarization, but exerted no influence on Treg differentiation 体内研究 β-Aminoarteether (SM934; 1-10mg/kg; oral administration; daliy; for 3 months) treatment significantly delays the progression of glomerulonephritis and increases the survival rate of NZB/W F1 mice. β-Aminoarteether treatment promots the IL-10 production of macrophages from NZB/W F1 mice Animal Model: Female NZB/W F1 mice (Six and half months old) Dosage: 1mg/kg, 3mg/kg, and 10mg/kg Administration: Oral administration; daliy; for 3 months Result: Significantly delayed the progression of glomerulonephritis and increased the survival rate of NZB/W F1 mice.
保存条件:-20℃